Status:
COMPLETED
An Assessment of Dual Site Left Ventricular Endocardial Pacing
Lead Sponsor:
Oxford University Hospitals NHS Trust
Conditions:
Atrial Fibrillation
Ventricular Tachycardia
Eligibility:
All Genders
60-85 years
Phase:
NA
Brief Summary
We are investigating ways to help patients with heart failure, which is caused by damaged hearts which function less well, and cause symptoms of breathlessness, fatigue, lack of energy and swelling. ...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 60 years or above.
- Having a suitable Atrial Fibrillation/flutter or Ventricular Tachycardia ablation procedure
- Evidence of abnormal Left Ventricular structure and function, as shown by Left Ventricular ejection fraction of less than 40%
Exclusion
- Severe peripheral vascular disease (that would make arterial access more risky)
- Haemodynamic instability (such that a longer procedure is inadvisable)
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02211456
Start Date
December 1 2014
End Date
November 1 2016
Last Update
March 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford University Hospitals NHS Trust
Oxford, Oxfordshire, United Kingdom, OX3 7AT